The musculoskeletal system drugs market comprises companies that
discover, develop, manufacture and distribute medications used in the treatment
of musculoskeletal diseases. Musculoskeletal diseases include arthritis,
osteoporosis, osteomalacia, carpal tunnel syndrome, tendonitis, rotator cuff
tear, muscular dystrophy, myasthenia gravis, lupus erythematosus and others.
Some of the major drugs in the market include Piroxicam Glaxo, Dolonex, Felden,
and Piroxicam Pfizer. The market numbers within this briefing are restricted to
pharmaceutical (drug) treatments and do not cover biologic treatments for these
conditions which are included in a separate briefing.
Read more:
The global musculoskeletal drugs
market has shown high growth in the past years with a CAGR of over 7.3%. The
year 2017 recorded a net market value of $130 billion as per TBRC’s in-house
consultants.
TBRC’s latest report show the historic
and future trends in the market for each year with sourced reasons to support
the growth claims.
The report also shows the global
musculoskeletal drugs market to grow at a higher CAGR by 2021 as compared to
2017, along with geographies best suited for investments with highest return
rate.
Sample
report:
Topical NSAIDs are being used for treatment of
acute musculoskeletal pain in adults. A NSAID penetrates the skin, enters
tissues or joints, and reduces processes causing pain in the tissue. It can be
used as a gel, cream, spray, or plaster to unbroken skin with musculoskeletal
pain. Topical NSAIDs also leads to very low level of drug in the blood as
compared to oral drugs, thus, minimizing the risk of harmful effects. In June
2015, medical research organization Cochrane published the results of its
clinical trials to compare topical NSAIDs with placebo or other medicines in
patients above 16 years with musculoskeletal pain. These results indicate that
gel formulations of NSAIDs diclofenac and ketoprofen were more effective in
treatment of strain, sprain, or muscle pull, as compared to placebo
Request
for Discount: https://www.thebusinessresearchcompany.com/sample.aspx?id=278&type=discount
Companies included in the report are F.
Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Pfizer Inc., Abbott Laboratories
Inc., and Daiichi Sankyo Company, Limited.
About The
Business Research Company.
The Business Research Company is a Business Intelligence Company
which excels in company, market and consumer research. It has offices in the
UK, the US and India and a network of trained
researchers in 15 countries
globally.
Contact
Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on Linkedin: https://in.linkedin.com/company/the-business-research-company
